These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6120037)

  • 1. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver.
    Campbell HA; Pitot HC; Potter VR; Laishes BA
    Cancer Res; 1982 Feb; 42(2):465-72. PubMed ID: 6120037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of neoplasia. Newer insights into an old problem.
    Pitot HC
    Am J Pathol; 1977 Nov; 89(2):402-11. PubMed ID: 21565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
    Glauert HP; Beer D; Rao MS; Schwarz M; Xu YD; Goldsworthy TL; Coloma J; Pitot HC
    Cancer Res; 1986 Sep; 46(9):4601-6. PubMed ID: 2873887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of a choline-devoid diet and phenobarbital in promoting the emergence of foci of gamma-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogen-treated rats.
    Shinozuka H; Lombardi B
    Cancer Res; 1980 Oct; 40(10):3846-9. PubMed ID: 6108159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
    Pitot HC; Goldsworthy T; Campbell HA; Poland A
    Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital.
    Hanigan MH; Pitot HC
    Cancer Res; 1985 Dec; 45(12 Pt 1):6063-70. PubMed ID: 3904978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
    Pitot HC; Goldsworthy TL; Moran S; Kennan W; Glauert HP; Maronpot RR; Campbell HA
    Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal use of sampled tissue sections for estimating the number of hepatocellular foci.
    Nychka D; Pugh TD; King JH; Koen H; Wahba G; Chover J; Goldfarb S
    Cancer Res; 1984 Jan; 44(1):178-83. PubMed ID: 6360345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroform inhibits the development of diethylnitrosamine-initiated, phenobarbital-promoted gamma-glutamyltranspeptidase and placental form glutathione S-transferase-positive foci in rat liver.
    Reddy TV; Daniel FB; Lin EL; Stober JA; Olson GR
    Carcinogenesis; 1992 Aug; 13(8):1325-30. PubMed ID: 1354081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative developmental and phenotypic properties of altered hepatocyte foci and hepatic tumors in rats.
    Peraino C; Carnes BA; Stevens FJ; Staffeldt EF; Russell JJ; Prapuolenis A; Blomquist JA; Vesselinovitch SD; Maronpot RR
    Cancer Res; 1988 Aug; 48(15):4171-8. PubMed ID: 3390811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration.
    Goldsworthy T; Campbell HA; Pitot HC
    Carcinogenesis; 1984 Jan; 5(1):67-71. PubMed ID: 6140089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary oat lipids-induced novel DNA modifications and suppression of altered hepatic foci formation.
    Li D; Wang M; Paul GP; Pitot HC; Dragan Y
    Nutr Cancer; 1999; 33(1):40-5. PubMed ID: 10227042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes and the development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis.
    Saha BK; Bhattacharya R; Chatterjee M
    Cell Biochem Funct; 2002 Sep; 20(3):195-204. PubMed ID: 12125095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term in vivo initiation/promotion bioassay for hepatocarcinogens.
    Ford JO; Pereira MA
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):39-46. PubMed ID: 6111580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
    Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
    Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methapyrilene effects on initiation and promotion of gamma-glutamyl-transpeptidase positive foci in rat liver.
    Couri D; Wilt SR; Milks MM
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):51-61. PubMed ID: 6120543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.
    Thomas RS; Conolly RB; Gustafson DL; Long ME; Benjamin SA; Yang RS
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):128-37. PubMed ID: 10896854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of altered hepatic foci by 2,3',4,4',5-pentachlorobiphenyl in Sprague-Dawley female rats.
    Haag-Grönlund M; Wärngård L; Flodström S; Scheu G; Kronevi T; Ahlborg UG; Fransson-Steen R
    Fundam Appl Toxicol; 1997 Jan; 35(1):120-30. PubMed ID: 9024679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.